SCHEMBL4200281

SCHEMBL4200281

C=CC(=O)OC(COc1ccccc1)COc1ccc(Sc2ccc(OCC(COc3ccccc3)OC(=O)C=C)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
MTNR1A P48039 3/20 0.38
MTNR1B P49286 3/20 0.38
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GLA P06280 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
ALOX5 P09917 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
TP53 P04637 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853211 0.96 THRB (0.48) THRBSMN1; SMN2LMNAPPARGPPARA
SCHEMBL14173314 0.90 THRB (0.42) THRBSMN1; SMN2LMNAGAAHPGD
SCHEMBL14173295 0.90 THRB (0.42) THRBSMN1; SMN2LMNAGAAHPGD
SCHEMBL5088322 0.90 THRB (0.57) THRBSMN1; SMN2LMNAPPARGPPARA
SCHEMBL4198635 0.90 THRB (0.47) THRBLMNAPPARAMTNR1AMTNR1B
SCHEMBL14546497 0.87 THRB (0.51) THRBSMN1; SMN2LMNAPPARGPPARA
SCHEMBL19944468 0.87 THRB (0.51) THRBSMN1; SMN2LMNAPPARGPPARA
SCHEMBL17231286 0.87 THRB (0.59) THRBSMN1; SMN2LMNAPPARGPPARA
SCHEMBL4186164 0.85 MAPT (0.48) THRBSMN1; SMN2LMNARAB9AMAPT
SCHEMBL11957662 0.85 THRB (0.51) THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 THRB 1009/4885SMN1; SMN2 1334/4885LMNA 4549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.